NASDAQ:CPRX - Catalyst Pharmaceuticals, Inc.
$4.18
 $0.13
+3.33%
11:55AM EDT
2019-07-22
Catalyst Pharmaceuticals, Inc., formerly Catalyst Pharmaceutical Partners, Inc., is a development-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for people with rare debilitating diseases. The Company has three drugs in development: Firdapse, CPP-109 and CPP-115. The Company's Firdapse is indicated for the treatments of lambert-eaton myasthenic syndrome (LEMS) and congenital myasthenic syndromes (CMS). Firdapse consists of the phosphate salt of amifampridine. The Company has completed the Phase III trial of Firdapse. The Company's CPP-109 (vigabatrin) is a gamma-aminobutyric acid (GABA) aminotransferase inhibitor. CPP-109 is indicated for the treatment of Tourette's Disorder. The Company's CPP-115 is a GABA aminotransferase inhibitor. CPP-115 is indicated for the treatment of selected neurological indications, such as complex partial seizures and Tourette's Disorder, and epilepsy. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  CPRX     avg for
industry  
  avg for
sector  
42 stocks weight:  20. 71   217. 37   399. 45  
42 stocks rank:  3. 16 K 1. 27 K 716. 99  
# analyst opinions:  6. 00   13. 21   13. 71  

quick ratio:  5. 86   5. 49   1. 88  
current ratio:  6. 08   5. 87   2. 36  

target price low:  5. 50   83. 44   114. 90  
target price avg:  8. 50   106. 20   137. 90  
target price high:  10. 00   132. 30   158. 97  
1-yr high:  6. 11   111. 86   142. 57  
last close:  4. 05   86. 79   125. 44  
50-day avg:  3. 69   86. 68   122. 63  
200-day avg:  3. 42   89. 22   121. 38  
1-yr low:  1. 92   69. 78   100. 51  
volume:  797. 93 K 2. 62 M 3. 43 M
50-day avg volume:  2. 05 M 3. 20 M 4. 16 M
200-day avg volume:  1. 95 M 2. 99 M 4. 75 M

1-day return:  -2. 17 % -1. 30 % -0. 99 %
this week return:  -0. 49 % 0. 45 % -0. 20 %
12-wk return:  -29. 07 % 0. 94 % 4. 84 %
52-wk return:  34. 42 % -1. 30 % 10. 55 %

enterprise value (EV):  372. 08 M 45. 10 B 122. 38 B
market cap:  416. 56 M 38. 96 B 108. 40 B
EBITDA:  -30. 31 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  -12. 28   5. 38   11. 93  
enterprise/revenue (EV/R):  28. 74   57. 92   10. 21  
total revenue:  12. 95 M 9. 91 B 39. 98 B
total debt:  1. 16 M 10. 90 B 17. 48 B
debt/equity:  2. 26   57. 18   120. 05  
net income (common):  -28. 95 M 2. 07 B 4. 05 B

shares outstanding:  102. 85 M 538. 09 M 1. 24 B
shares:  72. 01 M 548. 00 M 1. 22 B
shares short:  6. 51 M 10. 98 M 11. 87 M
shares short prior month:  5. 56 M 9. 32 M 12. 05 M
short ratio:  4. 36   5. 60   3. 34  
short % of float:  7. 89 % 6. 48 % 2. 64 %
total cash/share:  0. 44   10. 98   9. 19  
total cash:  45. 63 M 5. 93 B 6. 10 B
free cash flow:  -17. 73 M 2. 92 B 4. 55 B
operating cash flow:  -27. 59 M 3. 80 B 5. 78 B

book value:  0. 50   13. 35   27. 45  
price/book:  8. 13   4. 60   8. 78  
gross profits:  500. 00 K 7. 44 B 36. 13 B
operating margins:  -234. 39 % -308. 40 % -28. 55 %
EBITDA margins:  -234. 05 % 13. 17 % 23. 38 %
profit margins:  -223. 57 % 10. 44 % 14. 18 %
gross margins:  86. 78 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  -0. 28   2. 10   4. 23  
forward EPS:  0. 35   3. 45   7. 10  
P/E:  -14. 36   1. 90   32. 10  
forward P/E:  11. 57   6. 46   15. 47  
PE/G:  3. 09   0. 70   -0. 54  
growth:  -4. 65 % 265. 63 % 79. 11 %
earnings high:  0. 04   0. 89   1. 68  
earnings avg:  0. 02   0. 70   1. 57  
earnings low:  0. 00   0. 46   1. 46  
revenue high:  23. 00 M 2. 57 B 11. 07 B
revenue avg:  18. 49 M 2. 51 B 10. 91 B
revenue low:  14. 32 M 2. 45 B 10. 73 B
return on assets:  -27. 06 % -2. 34 % 5. 28 %
return on equity:  -45. 44 % -90. 08 % 133. 53 %
revenue/share:  0. 13   12. 72   60. 04  

beta (1yr vs S&P500):  1. 42   1. 27   0. 91  
sharpe (1yr):  0. 79   0. 16   0. 77  

held % insiders:  6. 89 % 6. 06 % 3. 29 %
held % institutions:  52. 00 % 78. 22 % 69. 37 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : CPRX
.    101.561 =       101.561 :: --> INITIAL WEIGHT <--
.    - 0.282 =       101.279 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.369 =       239.895 :: P/E factor
.    x 0.911 =       218.474 :: PE/G factor
.    x 1.646 =       359.583 :: beta factor
.    x 0.923 =       331.716 :: sharpe factor
.    x 2.964 =       983.276 :: current ratio factor
.    x 1.098 =      1079.726 :: quick ratio factor
.    x 1.109 =      1197.162 :: short ratio factor
.    x 1.496 =       1791.07 :: EV/R factor
.    x 1.093 =      1957.109 :: price-to-book factor
.    x 4.964 =       9715.79 :: debt-to-revenue factor
.     x 1.02 =      9906.094 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =     21008.775 :: sector+industry 1-year gains factor
.    x 1.009 =     21206.847 :: industry 12-weeks return factor
.    x 1.308 =     27736.193 :: industry 2-weeks return factor
.    x 1.405 =     38960.239 :: 5-day avg > 200-day avg
.    x 1.484 =     57801.429 :: 5-day avg > 50-day avg
.    x 1.078 =      62320.91 :: 50-day avg > 200-day avg
.    x 0.998 =     62171.943 :: "drift" penalty 3 days ago
.    / 2.056 =     30240.356 :: overall "drift" factor
.    x 0.864 =     26137.903 :: largest single-day jump factor
.    x 0.076 =      1990.701 :: low price factor
.    x 1.206 =      2400.664 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.    x 0.793 =      1903.963 :: forward EPS factor
.    x 0.925 =      1760.816 :: forward P/E factor
.    x 1.185 =      2086.061 :: industry recommendation factor
.    x 1.003 =      2091.829 :: factor historical industry gain for week 29
.    x 1.742 =      3644.773 :: target low factor
.    x 1.349 =      4918.281 :: target mean factor
.    x 1.051 =      5168.658 :: target high factor
.     x 11.1 =     57373.201 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        15.477 :: reduced for readability
.    + 5.235 =        20.712 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     20.712 :: FINAL WEIGHT for NASDAQ:CPRX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org